Patents by Inventor Eric GOFFIN

Eric GOFFIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling
    Patent number: 12318388
    Abstract: New pyrimidine derivatives together with a membrane penetrating agent, optionally with a detectable isotope and pharmaceutical composition for use in treatment or prevention of Gram-negative bacterial infection in a host mammal in need of such treatment or prevention and use as inhibitors of Gram-negative biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers. New pyrimidine derivatives together with a membrane penetrating agent; for use as radiotracer in diagnosing or prognosing Gram-negative bacterial infection in a host mammal.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: June 3, 2025
    Assignee: UNIVERSITÉ DE LIÈGE
    Inventors: Patrizio Lancellotti, Cécile Oury, Bernard Pirotte, Lucia Musumeci, Nicolas Jacques, Eric Goffin
  • USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES
    Publication number: 20220143226
    Abstract: A method of imaging a bacterial infection in a host mammal using Triazolo[4,5-d]pyrimidine derivatives of formula (I): Also disclosed are compositions including the triazolo[4,5-d]pyrimidine derivative.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Inventors: Cécile Oury, Patrizio Lancellotti, Alain Nchimi, André Luxen, Eric Goffin, Adrien Stouse
  • PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF GRAM-NEGATIVE BACTERIAL INFECTION, CONTAMINATION AND FOULING
    Publication number: 20210290625
    Abstract: New pyrimidine derivatives together with a membrane penetrating agent, optionally with a detectable isotope and pharmaceutical composition for use in treatment or prevention of Gram-negative bacterial infection in a host mammal in need of such treatment or prevention and use as inhibitors of Gram-negative biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers. New pyrimidine derivatives together with a membrane penetrating agent; for use as radiotracer in diagnosing or prognosing Gram-negative bacterial infection in a host mammal.
    Type: Application
    Filed: May 21, 2021
    Publication date: September 23, 2021
    Inventors: Patrizio LANCELLOTTI, Cécile OURY, Bernard PIROTTE, Lucia MUSUMECI, Nicolas JACQUES, Eric GOFFIN